IL6 and neoplasm: After establishing primary tumours with 9607-shIL-6 cells or control GFP-9607 cells in tumour self-seeding models, the seeding of RFP-F5M2 cells (CTCs) was significantly reduced in the IL-6 shRNA group compared with the control group (Figures 5c and 5d).